Salmeterol
(4)
Salsalate
(2)
Samarium
(1)
Saquinavir
(6)
Sargramostim
(3)
Scopolamine
(5)
Secretin
(1)
Selegiline
(3)
Selenium
(1)
Sermorelin
(1)
Sertraline
(5)
Sevelamer
(3)
Sevoflurane
(1)
Sibutramine
(4)
Sildenafil
(16)
Silver Sulfadiazine
(1)
Simvastatin
(5)
Sincalide
(1)
Sirolimus
(3)
Skin Graft
(1)
Sodium Ferric Gluconate
(1)
Sodium Fluoride
(3)
Sodium Hyaluronate
(4)
Sodium Phosphate Monobasic Monohydrate
(1)
Sodium Polystyrene
(1)
Sodium Sulfactemide
(3)
|
Sodium Tetradecyl
(1)
Somatrem
(1)
Somatropin
(4)
Sotalol
(3)
Sparfloxacin
(2)
Spectinomycin
(1)
Spironolactone
(2)
Stanozolol
(1)
Stavudine
(5)
Streptokinase
(4)
Streptomycin
(2)
Streptozocin
(2)
Succimer
(1)
Succinylcholine
(2)
Sucralfate
(2)
Sulfacetamide
(3)
Sulfadoxine
(1)
Sulfamethoxazole
(2)
Sulfasalazine
(2)
Sulfathiazole
(1)
Sulfinpyrazone
(2)
Sulfoxide
(1)
Sulindac
(2)
Sulphonamides
(4)
Sumatriptan
(4)
SomatoKine
This site describes this drug candidate (rhIGF-1/IGFBP-3) and some of its therapeutic uses for which Insmed Incorporated is succesfully developing the candidate.
| |